You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Organic Anion Transporting Polypeptide 1B1/1B3

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Liver Cirrhosis Trial (Rosuvastatin, Digoxin, Metformin hydrochlorid)

Not yet recruiting
  • Liver Cirrhosis
  • (no location specified)
Feb 27, 2023

Healthy Volunteers Trial in Lincoln (TAK-906, Rifampin)

Completed
Has Results
  • Healthy Volunteers
  • Lincoln, Nebraska
    Celerion
Nov 13, 2020

Rheumatoid Arthritis Trial in Saint Paul (Atorvastatin, Pravastatin, Rosuvastatin)

Completed
Has Results
  • Rheumatoid Arthritis
  • Saint Paul, Minnesota
    Prism Research, LLC
May 26, 2022

Healthy Participants Trial in Brooklyn (AZD5462, Midazolam, Rosuvastatin)

Completed
  • Healthy Participants
  • Brooklyn, Maryland
    Research Site
Oct 10, 2022

Nicotinamide Adverse Reaction Trial (Nicotinamide)

Not yet recruiting
  • Nicotinamide Adverse Reaction
  • (no location specified)
Aug 29, 2023

Learn About Interferon-beta Exposure of Pregnant Women During

Not yet recruiting
  • Multiple Sclerosis (MS)
  • Avonex (IFNβ-1-a, Biogen Netherlands B.V)
  • +5 more
  • Multiple Locations, Finland
  • +1 more
Sep 19, 2023

Inflammasome NLRP3 And IL-1B Gene Expression in COVID-19 Patients Trial in Assiut (Quantitative Real Time Polymerase chain

Recruiting
  • Inflammasome NLRP3 And IL-1B Gene Expression in COVID-19 Patients
  • Quantitative Real Time Polymerase chain reaction (qRT-PCR)
  • ELISA and colorimeter
  • Assiut, Egypt
    Biochemistry department,Faculty of medicine
Oct 10, 2023

Locally Advanced Solid Tumor, Metastatic Solid Tumor Trial in Providence (TY-2136b)

Not yet recruiting
  • Locally Advanced Solid Tumor
  • Metastatic Solid Tumor
  • Providence, Rhode Island
    Rhode Island Hospital, Brown University
Mar 2, 2023

People Who Have Genetic Changes and Features of Autism: Simons

Recruiting
  • 16P11.2 Deletion Syndrome
  • +184 more
    • New York, New York
    • +1 more
    Jan 6, 2023

    Immune System Disorder (Healthy Volunteers) Trial in Miami (Belumosudil, UGT1A1 victim drug, P-gp victim drug)

    Completed
    • Immune System Disorder (Healthy Volunteers)
    • Miami, Florida
      Investigational Site Number: 8400001
    Apr 11, 2023

    Nasal IL 1 Beta ,IL 3 Level and Their Effects in COPD Patients

    Not yet recruiting
    • Copd Patients
    • IL B,IL 3 in nasal swap and serum
    • (no location specified)
    Aug 4, 2023

    MDS, Ferroptosis Trial in Pessac (Biological sampling)

    Not yet recruiting
    • Myelodysplastic Syndromes
    • Ferroptosis
    • Biological sampling
    • Pessac, France
    • +2 more
    Jun 19, 2023

    Solid Tumor Trial in Belgium, Netherlands (INT-1B3)

    Recruiting
    • Solid Tumor
    • Brussels, Wallonie, Belgium
    • +3 more
    Feb 4, 2022

    HLA-A2 Positive Cells Present, Refractory Melanoma Trial in Buffalo (Alpha-type-1 Polarized Dendritic Cells, Celecoxib, PD-1

    Recruiting
    • HLA-A2 Positive Cells Present
    • Refractory Melanoma
    • Alpha-type-1 Polarized Dendritic Cells
    • +5 more
    • Buffalo, New York
      Roswell Park Cancer Institute
    Dec 12, 2022

    Long COVID Trial (LAU-7b for 3 cycles, LAU-7b for 1 cycle, then , Placebo for 3 cycles)

    Not yet recruiting
    • Long COVID
    • LAU-7b for 3 cycles
    • +2 more
    • (no location specified)
    Aug 16, 2023

    Chronic Inducible Urticaria Trial in Canada, United States (Oral EP262)

    Recruiting
    • Chronic Inducible Urticaria
    • Oral EP262
    • Tampa, Florida
    • +5 more
    Sep 18, 2023

    COVID-19 Trial in Newport Beach (hAd5-S-Fusion+N-ETSD, Placebo (0.9% (w/v) saline))

    Completed
    • COVID-19
    • hAd5-S-Fusion+N-ETSD
    • Placebo (0.9% (w/v) saline)
    • Newport Beach, California
      Hoag Memorial Hospital Presbyterian
    Sep 1, 2023

    Breast Tumors Trial in Chuo Ku, Koto-Ku (H3B-6545, Antihistamine)

    Active, not recruiting
    • Breast Neoplasms
    • Chuo Ku, Japan
    • +1 more
    Dec 19, 2022

    Pharmacokinetics, Bioavailability Trial in Nottingham (Sorafenib - Period 1, XS005 Sorafenib Capsule A - Period 1, XS005

    Completed
    • Pharmacokinetics
    • Bioavailability
    • Sorafenib - Period 1
    • +8 more
    • Nottingham, United Kingdom
      Quotient Sciences
    Jul 20, 2023

    Celiac Disease Trial in Saint Paul, Columbus (Cohort 1 in Part A, Cohort 2 in Part A, Cohort 3 in Part A)

    Recruiting
    • Celiac Disease
    • Cohort 1 in Part A
    • +6 more
    • Saint Paul, Minnesota
    • +1 more
    Jan 19, 2023

    Recurrent B-Cell Non-Hodgkin Lymphoma, Recurrent Follicular Lymphoma, Recurrent Indolent Adult Non-Hodgkin Lymphoma Trial in

    Suspended
    • Recurrent B-Cell Non-Hodgkin Lymphoma
    • +7 more
    • Philadelphia, Pennsylvania
      Sidney Kimmel Cancer Center at Thomas Jefferson University
    Jan 20, 2023

    NSCLC Trial in Jinan (DZD9008 and Probe drugs (midazolam, digoxin, rosuvastatin))

    Recruiting
    • Non-small Cell Lung Cancer
    • DZD9008 and Probe drugs (midazolam, digoxin, rosuvastatin)
    • Jinan, Shandong, China
      Shandong Cancer Hospital (Shandong Provincial Institute of Cance
    Jun 22, 2023

    Healthy Volunteers (Diabetes, Type 2) Trial in Harrow (Semaglutide B, 1.34 mg/mL, Semaglutide D, 1.0 mg/mL)

    Completed
    • Healthy Volunteers (Diabetes Mellitus, Type 2)
    • Semaglutide B, 1.34 mg/mL
    • Semaglutide D, 1.0 mg/mL
    • Harrow, Middlesex, United Kingdom
      Novo Nordisk Investigational Site
    Jan 29, 2023

    COVID-19 Trial in Canada (Artesunate, Imatinib, Infliximab)

    Recruiting
    • COVID-19
    • Calgary, Alberta, Canada
    • +56 more
    Jan 12, 2023

    Children After Hospitalization in Intensive Care Unit

    Not yet recruiting
    • Renal Disease
    • +7 more
    • neurocognitive tests
    • Calgary, Alberta, Canada
    • +7 more
    Nov 3, 2023